Literature DB >> 3921856

Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.

M M Caramona, D Araújo, F Brandão.   

Abstract

Specific inhibitors of MAO A (clorgyline 0.1 mumol/l) and of MAO B [(-)deprenyl 10 mumol/l] were used in dog saphenous vein strips in order to study the relative influence of the two types of MAO on: 1. Termination of contractile response to exogenous noradrenaline (NA); 2. Metabolism and accumulation of exogenous (3H)-NA; 3. Metabolism of 3H-NA released by electrical stimulation. To study the termination of contractile response to exogenous NA, the oil immersion technique was used to determine the time for half-relaxation. The experiments were performed on strips with or without treatment with cocaine 10 mumol/l (to inhibit neuronal uptake) plus U-0521 100 mumol/l (to inhibit catechol-O-methyl transferase) before and after exposure to MAO inhibitors. Clorgyline, but not (-)deprenyl enhanced significantly the time for half-relaxation of the strips, whether cocaine was present or not. To study the metabolism and accumulation of exogenous 3H-NA, the strips were incubated (with or without preincubation with cocaine) with 3H-NA 0.23 mumol/l and 2.3 mumol/l in the presence and in the absence of MAO inhibitors. The formation of deaminated metabolites was significantly reduced by clorgyline, but not by deprenyl. To study the metabolism of 3H-NA released by electrical stimulation, the strips were incubated with 3H-NA 1.4 mumol/l. In the presence of cocaine and U-0521, field stimulation was applied during two periods of 5 min (10 Hz, 100 V, 2 ms), in the absence or presence of MAO inhibitors. Under these experimental conditions clorgyline, but not deprenyl, abolished DOPEG formation, without affecting the other metabolites.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921856     DOI: 10.1007/bf00692908

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Inactivation of norepinephrine in an isolated vein.

Authors:  F Brandao
Journal:  J Pharmacol Exp Ther       Date:  1977-10       Impact factor: 4.030

2.  3 H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens.

Authors:  L O Farnebo; T Malamfors
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

4.  A method for the study of mechanisms of drug disposition in smooth muscle.

Authors:  S Kalsner; M Nickerson
Journal:  Can J Physiol Pharmacol       Date:  1968-09       Impact factor: 2.273

5.  Disposition of norepinephrine and epinephrine in vascular tissue, determined by the technique of oil immersion.

Authors:  S Kalsner; M Nickerson
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

6.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

7.  False labelling of commercially available 3H-catecholamines?

Authors:  K Starke; A Steppler; A Zumstein; M Henseling; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

8.  Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane.

Authors:  M A Luchelli-Fortis; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

10.  Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.

Authors:  M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more
  5 in total

1.  Proceedings of the British Pharmacological Society. Nottingham, 7th-9th September 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.

Authors:  D Hovevey-Sion; J P Finberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.

Authors:  M M Caramona; J V Esplugues; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

4.  Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.

Authors:  M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

5.  The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.

Authors:  M Q Paiva; M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.